AbbVie Inc.·4

Aug 7, 5:00 PM ET

Donoghoe Nicholas 4

4 · AbbVie Inc. · Filed Aug 7, 2025

Insider Transaction Report

Form 4
Period: 2025-08-05
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Transactions
  • Sale

    Common Stock, $0.01 par value

    2025-08-05$198.27/sh3,234.17$641,23968,308 total
  • Sale

    Common Stock, $0.01 par value

    2025-08-05$198.59/sh10,061$1,998,01458,247 total
Footnotes (3)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.26 to $198.37 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This reflects shares acquired pursuant to a dividend reinvestment plan.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.56 to $198.73 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4-08072025_050802.xmlPrimary